CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion · Stock Option (Right to Buy) | −3,086 | 0 | ||
| 2017-03-13 | EMPFIELD JAMES R. SVP, Drug Discovery | Grant or award · Stock Option (Right to Buy) | +27,500 | 27,500 | ||
| 2017-03-13 | COHEN CHARLES J. VP, Biology | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-03-13 | WINQUIST RAYMOND Head, Translational Research | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-03-13 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Grant or award · Stock Option (Right to Buy) | +27,500 | 27,500 | ||
| 2017-03-13 | PIMSTONE SIMON N. President & CEO | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2017-03-13 | MORTIMER IAN CFO & COO | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2017-03-13 | GOLDBERG Y. PAUL SVP, Clinical Development | Grant or award · Stock Option (Right to Buy) | +27,500 | 27,500 | ||
| 2017-01-26 | TARNOW MICHAEL M Director | Gift | −7,201 | 55,167 | ||
| 2016-12-15 | HOLLER FRANK A Director | Sale | −30,000 | $7.85 | $236K | 115,869 |
| 2016-12-12 | TARNOW MICHAEL M Director | Exercise or conversion | +14,403 | $3.21 | $46K | 69,570 |
| 2016-12-12 | TARNOW MICHAEL M Director | Gift | −7,202 | 62,368 | ||
| 2016-12-12 | TARNOW MICHAEL M Director | Exercise or conversion · Stock Option (Right to Buy) | −14,403 | 0 | ||
| 2016-12-06 | PATOU GARY Director | Exercise or conversion | +12,345 | $3.21 | $40K | 16,431 |
| 2016-12-06 | PATOU GARY Director | Shares withheld for taxes | −4,403 | $7.90 | $35K | 12,028 |
| 2016-12-06 | PATOU GARY Director | Exercise or conversion · Stock Option (Right to Buy) | −12,345 | 0 | ||
| 2016-12-01 | AZAB MOHAMMAD Director | Exercise or conversion | +12,345 | $3.21 | $40K | 17,283 |
| 2016-12-01 | AZAB MOHAMMAD Director | Shares withheld for taxes | −4,408 | $7.80 | $34K | 12,875 |
| 2016-12-01 | AZAB MOHAMMAD Director | Exercise or conversion · Stock Option (Right to Buy) | −12,345 | 0 | ||
| 2016-09-27 | Svoronos Dawn Director | Grant or award · Stock Option (Right to Buy) | +5,144 | 5,144 |
Page 33 of 42 · 836 trades